ORIENT BIO Inc. (002630.KS)
KRW 1957.0
(2.35%)
KRW 1957.0
(2.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.75 Billion | 1.15 Billion | 2.35 Billion | 8.73 Billion | -4.67 Billion | -11.53 Billion |
| Net Income | 12.87 Billion | -12.42 Billion | 34.19 Billion | -15.63 Billion | -11.64 Billion | -30.17 Billion |
| Depreciation & Amortization | 2.68 Billion | 3.09 Billion | 3.92 Billion | 4.69 Billion | 4.25 Billion | 8.07 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 473.91 Million | -2.86 Billion | -2.28 Billion | 394.33 Million | 790.78 Million | 4.63 Billion |
| Other non-cash items | -7.84 Billion | 13.35 Billion | -33.48 Billion | 19.28 Billion | 1.93 Billion | 5.91 Billion |
| Investing Cash Flow | -3.11 Billion | -20.65 Billion | 16.77 Billion | -4.03 Billion | -347.25 Million | -26.73 Billion |
| Investments in PPE | -925.25 Million | -485.64 Million | -2.21 Billion | -256.16 Million | -1.88 Billion | -18.43 Billion |
| Acquisitions | 1.9 Million | -720 Million | 26.46 Billion | 4.65 Billion | 4.65 Billion | -5.69 Billion |
| Investment purchases | -32.1 Billion | -28.28 Billion | -7.72 Billion | -120 Million | -7.58 Billion | -6.5 Billion |
| Sales/Maturities of investments | 28.52 Billion | 10.07 Billion | 800 Million | 1 Million | 2.3 Billion | 555.28 Million |
| Other Investing Activities | 1.38 Billion | -1.23 Billion | -556.78 Million | -8.31 Billion | 2.16 Billion | 3.33 Billion |
| Financing Cash Flow | -570.35 Million | -6.79 Billion | -1.13 Billion | 3.87 Billion | -1.81 Billion | 23 Billion |
| Debt repayment | - | -6.03 Billion | -1.66 Billion | -202.37 Million | -2.26 Billion | -50.48 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -10.01 Million | -10.01 Million | - |
| Common Stock Issuance | - | 19.76 Million | 19.76 Million | 4.94 Billion | - | 32.83 Billion |
| Other Financing Activities | -570.35 Million | -781.57 Million | 514.2 Million | 4.49 Million | 460.42 Million | 40.65 Billion |
| Accounts receivables | -164.89 Million | 846.83 Million | -4.85 Billion | 201.27 Million | -2.5 Billion | -5.47 Billion |
| Accounts payables | 371.87 Million | -143.87 Million | 86.03 Million | 49.32 Million | -273.99 Million | 3.65 Billion |
| Inventory | 732.32 Million | -465.91 Million | 1.94 Billion | 2.17 Billion | 2.17 Billion | 7.22 Billion |
| Other working capital | -465.4 Million | -3.09 Billion | 542.35 Million | -2.03 Billion | 1.38 Billion | -772.49 Million |
| Cash at beginning of period | 5.93 Billion | 29.99 Billion | 10.94 Billion | 2.34 Billion | 9.16 Billion | 24.43 Billion |
| Cash at end of period | 6.1 Billion | 5.93 Billion | 29.99 Billion | 10.94 Billion | 2.34 Billion | 9.16 Billion |
| Capital Expenditure | -925.25 Million | -485.64 Million | -2.21 Billion | -256.16 Million | -1.88 Billion | -18.43 Billion |
| Effect of forex changes on cash | 104.39 Million | 2.23 Billion | 1.06 Billion | 8.97 Million | 15.34 Million | -10.00 |
| Net cash flow / Change in cash | 174.71 Million | -24.05 Billion | 19.05 Billion | 8.59 Billion | -6.82 Billion | -15.26 Billion |
| Free Cash Flow | 2.83 Billion | 674.29 Million | 140.52 Million | 8.48 Billion | -6.55 Billion | -29.96 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.78 Billion | 10.99 Billion | 12.87 Billion | 213.31 Million | -649.99 Million | 2.31 Billion |
| Depreciation & Amortization | 480.8 Million | 622.46 Million | 2.68 Billion | 643.75 Million | 731.28 Million | 686.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.07 Billion | 1.19 Billion | 473.91 Million | 510.94 Million | -1.12 Billion | -106.38 Million |
| Other non-cash items | 8.48 Billion | -10.69 Billion | -7.84 Billion | 589.1 Million | 212.46 Million | -1.61 Billion |
| Investing Cash Flow | -1.17 Billion | -601.34 Million | -3.11 Billion | 1.08 Billion | -2.13 Billion | -1.46 Billion |
| Investments in PPE | -1.8 Billion | -589.75 Million | -925.25 Million | -226 Million | -107 Million | -2.5 Million |
| Acquisitions | 3.72 Million | 1.9 Million | 1.9 Million | - | -2 Billion | -1.8 Billion |
| Investment purchases | -5.28 Billion | -815 Million | -32.1 Billion | -19.61 Billion | -30 Million | -7.84 Billion |
| Sales/Maturities of investments | 5.27 Billion | 800 Million | 28.52 Billion | 19.84 Billion | 107 Million | 7.87 Billion |
| Other Investing Activities | 639.99 Million | 1.5 Million | 1.38 Billion | 1.08 Billion | -104 Million | 303 Million |
| Financing Cash Flow | -206.4 Million | -200.12 Million | -570.35 Million | -193.34 Million | -88.43 Million | -88.43 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -206.4 Million | - | - | - | - | - |
| Accounts receivables | -1.15 Billion | -213.55 Million | -164.89 Million | 744.38 Million | -1.24 Billion | 550.38 Million |
| Accounts payables | 694.41 Million | 24.78 Million | 371.87 Million | 311.48 Million | 78.18 Million | -42.57 Million |
| Inventory | 37.89 Million | 664.34 Million | 732.32 Million | 162.59 Million | -38.28 Million | -56.33 Million |
| Other working capital | -649.88 Million | 718.28 Million | -465.4 Million | -707.51 Million | 81.67 Million | -557.85 Million |
| Cash at beginning of period | 6.1 Billion | 5.53 Billion | 5.93 Billion | 2.71 Billion | 5.71 Billion | 5.93 Billion |
| Cash at end of period | 4.47 Billion | 6.1 Billion | 6.1 Billion | 5.53 Billion | 2.71 Billion | 5.71 Billion |
| Capital Expenditure | -1.8 Billion | -589.75 Million | -925.25 Million | -226 Million | -107 Million | -2.5 Million |
| Effect of forex changes on cash | 25.87 Million | 27.78 Million | 104.39 Million | -32.65 Million | 52.75 Million | 56.51 Million |
| Net cash flow / Change in cash | -1.62 Billion | 573.29 Million | 174.71 Million | 2.81 Billion | -3 Billion | -216.61 Million |
| Free Cash Flow | -2.07 Billion | 757.22 Million | 2.83 Billion | 1.73 Billion | -937.76 Million | 1.28 Billion |
3380
GTLB
002165
EQNR
SMOP
FICO